Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its fourth-generation HIV combination antigen-antibody assay, the Elecsys HIV combi PT assay, has received FDA PMA approval from the U.S. Food and Drug Administration (FDA).
{iframe}http://www.prnewswire.com/news-releases/roche-receives-fda-approval-for-fourth-generation-hiv-combination-antigen-antibody-assay-allowing-detection-of-infection-with-high-sensitivity-and-specificity-300478889.html{/iframe}